ING Group’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.7M Sell
142,479
-56,287
-28% -$28.5M 0.4% 54
2025
Q4
$113M Sell
198,766
-9,107
-4% -$4.85M 0.68% 28
2025
Q3
$93M Buy
207,873
+129,687
+166% +$62.2M 0.5% 35
2025
Q2
$42.5M Sell
78,186
-19,256
-20% -$10.1M 0.26% 64
2025
Q1
$48.3M Buy
97,442
+43,248
+80% +$23.9M 0.33% 58
2024
Q4
$28.3M Sell
54,194
-18,054
-25% -$9.4M 0.19% 92
2024
Q3
$35.5M Sell
72,248
-54,248
-43% -$25.3M 0.21% 81
2024
Q2
$56.3M Sell
126,496
-15,243
-11% -$6.07M 0.33% 54
2024
Q1
$56.6M Sell
141,739
-5,303
-4% -$2M 0.39% 53
2023
Q4
$49.6M Buy
147,042
+23,245
+19% +$6.93M 0.4% 48
2023
Q3
$36.2M Buy
123,797
+8,005
+7% +$2.5M 0.32% 68
2023
Q2
$39.6M Buy
115,792
+66,940
+137% +$20.3M 0.3% 65
2023
Q1
$12.5M Buy
48,852
+1,837
+4% +$453K 0.12% 141
2022
Q4
$12.5M Buy
47,015
+19,333
+70% +$4.71M 0.13% 138
2022
Q3
$5.19M Sell
27,682
-46,706
-63% -$10M 0.09% 169
2022
Q2
$14.9M Sell
74,388
-3,154
-4% -$740K 0.17% 104
2022
Q1
$23.4M Sell
77,542
-14,226
-16% -$4.16M 0.24% 77
2021
Q4
$33M Buy
91,768
+19,540
+27% +$6.72M 0.29% 68
2021
Q3
$23.9M Sell
72,228
-38,211
-35% -$12.8M 0.31% 58
2021
Q2
$33.9M Buy
110,439
+87,057
+372% +$24.4M 0.54% 33
2021
Q1
$5.76M Sell
23,382
-9
-0% -$2.26K 0.12% 111
2020
Q4
$6.38M Buy
23,391
+15,621
+201% +$3.88M 0.14% 100
2020
Q3
$1.84M Buy
7,770
+4,812
+163% +$1.08M 0.08% 141
2020
Q2
$562K Sell
2,958
-3,402
-53% -$610K 0.02% 164
2020
Q1
$1.05M Buy
6,360
+4,179
+192% +$765K 0.04% 181
2019
Q4
$430K Buy
+2,181
New +$408K 0.01% 409
2019
Q3
Sell
-5,751
Closed -$1.01M 616
2019
Q2
$1.01M Buy
5,751
+4,329
+304% +$742K 0.02% 379
2019
Q1
$270K Sell
1,422
-1,629
-53% -$290K 0.01% 633
2018
Q4
$487K Sell
3,051
-65,037
-96% -$11M 0.01% 468
2018
Q3
$13M Sell
68,088
-15,207
-18% -$2.7M 0.23% 77
2018
Q2
$13.3M Sell
83,295
-146,586
-64% -$22.4M 0.25% 64
2018
Q1
$31.6M Buy
+229,881
New +$32.1M 0.57% 38
2017
Q1
Sell
-5,409
Closed -$383K 599
2016
Q4
$383K Sell
5,409
-12,312
-69% -$905K 0.01% 470
2016
Q3
$1.42M Buy
17,721
+3,159
+22% +$242K 0.02% 250
2016
Q2
$1.07M Buy
14,562
+4,428
+44% +$312K 0.01% 251
2016
Q1
$677K Sell
10,134
-32,490
-76% -$2.01M 0.01% 331
2015
Q4
$2.6M Buy
+42,624
New +$2.39M 0.02% 390
2015
Q2
Sell
-13,230
Closed -$743K 671
2015
Q1
$743K Buy
13,230
+630
+5% +$35.7K ﹤0.01% 638
2014
Q4
$741K Buy
+12,600
New +$702K ﹤0.01% 617
2014
Q2
Sell
-54,450
Closed -$2.65M 669
2014
Q1
$2.65M Sell
54,450
-188,550
-78% -$8.88M 0.01% 446
2013
Q4
$10.4M Sell
243,000
-27,000
-10% -$1.14M 0.05% 284
2013
Q3
$11.3M Hold
270,000
0.06% 276
2013
Q2
$15.2M Buy
+270,000
New +$14.9M 0.08% 223

Other funds holding ISRG

ING Group's ISRG Position: Q1 2026 in Review

ING Group reduced its Intuitive Surgical (ISRG) stake by 28% in Q1 2026, selling an estimated $28.5M and leaving 142,479 shares worth $65.7M. The position accounts for 0.4% of the portfolio, ranked #54.

ING Group first reported a position in ISRG in Q2 2013 and has held it in 43 quarters since. The position peaked at $113M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • ING Group held 142,479 shares of Intuitive Surgical worth $65.7M as of Q1 2026.
  • ING Group sold 56,287 Intuitive Surgical shares in Q1 2026, an estimated $28.5M.
  • Intuitive Surgical made up 0.4% of ING Group's portfolio in Q1 2026, its #54 holding.
  • ING Group first reported a position in Intuitive Surgical in Q2 2013 and has held it in 43 quarters since.
  • ING Group's Intuitive Surgical position peaked at $113M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on ING Group's 13F filing for Q1 2026, filed 11 May 2026.